Surufatinib plus toripalimab in patients with advanced solid tumors: a single-arm, open-label, phase 1 trial.
Yanshuo CaoMing LuYu SunJifang GongJie LiZhihao LuJian LiXiaotian ZhangYan LiZhi PengJun ZhouXicheng WangLin ShenPublished in: Journal of cancer research and clinical oncology (2022)
Clinicaltrials.gov Identifier: NCT03879057; registration date: March 18, 2019.